Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
9.74
-0.07 (-0.66%)
At close: Oct 6, 2026, 4:00 PM EDT
9.68
-0.05 (-0.56%)
After-hours: Oct 6, 2026, 4:15 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $687.01 million as of October 6, 2026. Its market cap has decreased by -37.99% in one year.
Market Cap
687.01M
Enterprise Value
642.65M
1-Year Change
-37.99%
Ranking
Category
Stock Price
$9.74
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $687.01M, an increase of 433.17%. That is a compound annual growth rate of 6.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 691.60M | -39.71% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 734.49M |
| Faeth Therapeutics | 732.58M |
| Olema Pharmaceuticals | 719.67M |
| Nuvectis Pharma | 714.19M |
| OmniAb | 708.05M |
| Verastem | 697.34M |
| Shattuck Labs | 675.44M |
| MiMedx Group | 669.04M |